Dr. Robert E. Ingham, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 18631 Alderwood Mall Pkwy Ste 310, Lynnwood, WA 98037 Phone: 425-774-8251 |
Dr. David Edward Welton, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 18631 Alderwood Mall Pkwy, Suite 310, Lynnwood, WA 98037 Phone: 425-774-8251 Fax: 425-775-1063 |
News Archive
An analysis of a new international registry reveals benefits of using a longer covered stent for interventional procedures in congenital heart disease patients with Sinus Venosus Atrial Septal Defect (SVASD).
The National Institute on Drug Abuse, part of the National Institutes of Health, awarded a $3.58 million grant to Sanford Burnham Prebys scientist Anthony Pinkerton, Ph.D., to advance a potential treatment for opioid-use disorders, called SBI-553.
Binge drinking is costing the U.S. economy more than $200 billion a year, mostly in lost workplace productivity, a U.S. health agency said on Monday.
Most children with rare genetic diseases spend years undergoing medical tests and waiting for a diagnosis - a long, exhausting process that takes its toll on children and their families. Almost half of these children never get a definitive diagnosis.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced the initiation of a global Phase 2b clinical trial evaluating aldoxorubicin compared to topotecan in subjects with extensive-stage small cell lung cancer (SCLC) who have relapsed or were refractory to prior chemotherapy.
› Verified 7 days ago